SEER Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 geg. 2024 @ 17:09):

Stats
Šios dienos apimtis	7 481.00
Vidutinė apimtis	528 427
Rinkos kapitalizacija	136.02M
EPS	$0 ( 2024-02-29 )
Kita pelno data	( $-0.310 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.560
ATR14	$0.00800 (0.38%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-07	Farokhzad Omid	Sell	52 857	Class A Common Stock
2024-02-06	Kogan Elona	Buy	123 153	Class A Common Stock
2024-02-22	Kogan Elona	Sell	12 684	Class A Common Stock
2024-02-06	Kogan Elona	Buy	140 000	Employee Stock Option (right to buy)
2024-02-06	Kogan Elona	Buy	79 729	Employee Stock Option (right to buy)

INSIDER POWER
86.11
Last 98 transactions
Buy: 6 813 760 \| Sell: 922 350

Tūris Koreliacija

Ilgas: -0.19 (neutral)

Trumpas: -0.07 (neutral)

Signal:(43.714) Neutral

Seer, Inc. Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
GXGX	0.92
CRON	0.911
NVTSW	0.908
IRBT	0.908
EVLO	0.906
CREG	0.903
SWAV	0.902
EPSN	0.899
HOL	0.898
BCAB	0.897

10 Labiausiai neigiamai susiję koreliacijos
BRIV	-0.911
PATK	-0.908
ALXN	-0.907
APMI	-0.906
GMFI	-0.905
ENTF	-0.905
CBRG	-0.904
ACAB	-0.903
ENER	-0.903
EMLD	-0.903

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Seer, Inc. Koreliacija - Valiuta/Žaliavos

0.66
( moderate )

0.22
( neutral )

0.00
( neutral )

0.72
( moderate )

-0.53
( weak negative )

Seer, Inc. Finansinės ataskaitos

Annual	2023
Pajamos:	$15.18M
Bruto pelnas:	$1.45M (9.54 %)
EPS:	$-1.350

FY	2023
Pajamos:	$15.18M
Bruto pelnas:	$1.45M (9.54 %)
EPS:	$-1.350

FY	2022
Pajamos:	$14.69M
Bruto pelnas:	$6.74M (45.91 %)
EPS:	$-1.420

FY	2021
Pajamos:	$0.00
Bruto pelnas:	$0.00 (0.00 %)
EPS:	$-1.164

Financial Reports:

No articles found.

Seer, Inc.

Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.